Efficacy of Hijamat  wet cupping therapy  in Iranian patients with nonalcoholic fatty  liver disease: a controlled clinical trial

Homayoon BASHIRI; Arezoo BOZORGOMID; Vahıd SHOJAEIMOTLAGH

doi:https://doi.org/10.3906/sag-1907-82

Makale detayları

Efficacy of Hijamat wet cupping therapy in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trial

Yazarlar:

Homayoon BASHIRI | Arezoo BOZORGOMID | Vahıd SHOJAEIMOTLAGH

Yayıncı:

TUBITAK

Dergi:

Turkish Journal of Medical Sciences 2020 Vol.50 Issue 2, pp.354-359

Belge Tipi:

Makale

Yayın Tarihi:

2/2020

Belge Dili:

İngilizce

Document ID (Org No.):

2000749585

Sıklık:

İki Aylık

eISSN:

1303-6165

pISSN:

1300-0144

DOI:

https://doi.org/10.3906/sag-1907-82

Özet:

 

Background/aim: Nonalcoholic fatty liver disease  NAFLD  is known to be the most prevalent chronic liver disease all over the world.  The incidence of this disease has dramatically increased during the last decade. Studies have shown a strong relationship between the  level of ferritin and the severity of NAFLD. The objective of the present study was to assess the effect of adding Hijamat, as an iron  reducing procedure, to standard lifestyle modification on the improvement of insulin resistance and liver enzymes in patients with  NAFLD.  Materials and methods: One hundred and twenty NAFLD patients participated in a randomized, controlled, single-blind trial design of  study. The control group received counselling for nutrition and physical activity for a period of 6 months. The treatment group received  the above items plus Hijamat for 3 times during 1 month. Ultrasound images of liver, HOMA-IR, and laboratory data including ALT,  AST were assessed pre- and postintervention.  Results: At the end of the study, a significant decrease was demonstrated in the serum level of HOMA-IR  -1.30 ± 0.88 vs -.02 ± 0.47,  P < 0.001  and serum levels of ALT  -6.50 ± 4.92 vs -2.38 ± 3.92, P < 0.001  and AST  -2.78 ± 4.29 vs -1.30 ± 2.33, P = 0.021  in the  Hijamat group were compared to the control group. Ultrasound images of the liver improved in 23.3% of the patients in the Hijamat  group, while the rate of improvement in the control group was 10%  P = 0.050 . Hijamat therapy was safe and tolerable in this trial.  Conclusions: Hijamat resulted in a relative improvement in fatty liver severity and improved HOMA-IR and liver enzymes more than  lifestyle modification alone in patients with NAFLD.

Makale detayları

Efficacy of Hijamat wet cupping therapy in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trial

Yazarlar: Homayoon BASHIRI | Arezoo BOZORGOMID | Vahıd SHOJAEIMOTLAGH

Yayıncı: TUBITAK

Dergi: Turkish Journal of Medical Sciences 2020 Vol.50 Issue 2, pp.354-359

Belge Tipi: Makale

Yayın Tarihi: 2/2020

Belge Dili: İngilizce

Document ID (Org No.): 2000749585

Sıklık: İki Aylık

eISSN: 1303-6165

pISSN: 1300-0144

DOI: https://doi.org/10.3906/sag-1907-82

Sayı

Yazarlar:

Homayoon BASHIRI | Arezoo BOZORGOMID | Vahıd SHOJAEIMOTLAGH

Yayıncı:

TUBITAK

Dergi:

Turkish Journal of Medical Sciences 2020 Vol.50 Issue 2, pp.354-359

Belge Tipi:

Makale

Yayın Tarihi:

2/2020

Belge Dili:

İngilizce

Document ID (Org No.):

2000749585

Sıklık:

İki Aylık

eISSN:

1303-6165

pISSN:

1300-0144

DOI:

https://doi.org/10.3906/sag-1907-82